Search bioRxiv⌕ Search

bioRxiv · 10.1101/459701

Natural avirulent Shigella boydii strain in the Brazilian Amazon lacks major virulence genes and present Type II, Type III and Type VI Secretion Systems

Abstract

BackgroundAmong Shigella species, Shigella boydii has always displayed a smaller role to the overall Shigella burden, frequently placed at third in epidemiological studies and described as restricted to Southeast Asia. Here we characterize an S. boydii isolated from an epidemiological study enrolling 1,339 Brazilian children from the Amazon region, in which Shigella species solely was the fourth cause of bacterial diarrhea. S. boydii strain 183 was isolated from rotavirus co-infected children with acute diarrhea. Here we aimed to characterize this strain regarding virulence and, immune response in a pulmonary model.\n\nMethodsAn in vitro HEp-2 epithelial cell invasion assay was used to compare the invasive phenotype of S. boydii strain 183 with clinical and highly virulent S. flexneri strain, both isolated from Brazilian children. A murine pulmonary model was performed to assess lung damage by histopathological analysis. mRNA expression of immune response key genes was retrieved by multiplex real-time PCR and correlations were obtained by network analysis. Broad genome analysis was performed to confirm S. boydii identity and define its virulence profile.\n\nResultsS. boydii strain 183 showed fewer invasion rates in vitro and tissue damage in vivo as compared to virulent S. flexneri 201. When compared to a survival challenge in mice, S. boydii had 100% survival against 10% of virulent S. flexneri. Overall, mRNA immune gene expression suggests a protective response against S. boydii strains 183, in contrast to the inflammatory response induced by the virulent S. flexneri strain 201. Network analysis with S. boydii strain 183 displayed IFN-{gamma} protagonism, contrasting with the correlations centralized on TNF- by the virulent S. flexneri strain 201. The genome showed a lack of effector proteins and enterotoxins in S. boydii strain 183, and sequencing analysis of Ipa invasins revealed mutations at functional sites. This avirulent S. boydii strain 183 presents the Type II Secretion System, T6SS, in addition to T3SS.\n\nConclusionsIn addition to causing no disease, S. boydii strain 183 lacks effector proteins and enterotoxins. The presence of T6SS additional secretion system could provide an advantage to establish this strain among commensal bacteria.\n\nAUTHOR SUMMARYThe Shigella genus is a human pathogen responsible to shigellosis and remains one of the significant causes of morbidity and mortality in children under five years old. This genus has four species, Shigella flexneri, Shigella sonnei, Shigella boydii, and Shigella dysenteriae. S. flexneri and S. sonnei are the most common in the worldwide infections; S. dysenteriae is rarely found, and S. boydii is responsible for 1% of the infections and is known to be restricted to Southeast Asia. Once S. boydii have a relatively small role in global Shigella disease, there are few studies regarding its virulence and mechanisms. Here we characterize an S. boydii isolated from Brazilian children from the Amazon region, and aimed to describe this strain regarding virulence. It is known that Shigella species use the Type 3 Secretion System (T3SS) to invade and colonize the human intestine. We found in S. boydii the presence of Type 2 Secretion System (T2SS), Type 6 Secretion System (T6SS), in addition to the T3SS. The T6SS have been described in S. sonnei only, granting a competitive advantage against S. flexneri mixed cultures. The presence of T6SS additional secretion system could provide a benefit to establish this strain among commensal bacteria.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Serra, P. T., Vercosa, J. V., Souza, R. M. d., Dantas, P. I. d. S., Rezende, A. d. O., Barros, A. P. M., Souza, A. R. d., Ribeiro-Alves, M., Pereira, M. d. S. F., Balieiro, A., Raiol, T., Mariuba, L. A. M., Moraes, M. O. d., Epiphanio, S., Matos, N. B., Mota, A. J. d., Pontes, G. S., Magalhaes Junior, P. F. C. d., Lacerda, M. V. G. d., Nogueira, P. A., Orlandi, P. P.. 2018-11-01. Natural avirulent Shigella boydii strain in the Brazilian Amazon lacks major virulence genes and present Type II, Type III and Type VI Secretion Systems. https://doi.org/10.1101/459701

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Microbially conjugated bile acids differentially affect the lifecycle and pathogenesis of Clostridioides difficile

Clostridioides difficile is a Gram-positive bacterium that causes C. difficile infection (CDI). In healthy adults, it has been proposed that the gut microbiota provides colonization resistance against C. difficile by competition through nutrient limitation and antagonism through secondary bile acid metabolism, the latter of which is mediated by the deconjugation of host-derived bile acids with bacterial bile salt hydrolases (BSH). Recently, BSHs have also shown an ability to reconjugate non-canonical (i.e., not glycine or taurine) amino acids to sterol cores, resulting in novel microbially conjugated bile acids (MCBAs). MCBAs have been associated with the resolution of recurrent CDI, though the mechanism underlying these effects are not well understood. To address this gap, we synthesized 36 MCBAs with nine amino acids (cysteine, isoleucine, leucine, phenylalanine, proline, serine, tryptophan, tyrosine, and valine) conjugated to the primary and secondary bile acids found in the human gut (CA, DCA, CDCA, and LCA) and tested their impact on various stages of C. difficiles lifecycle including bacterial outgrowth, membrane integrity, sporulation, and toxin activity. We show that BSH-mediated amidation of bile acid sterol cores can either increase or decrease inhibitory effects on C. difficile in an amino acid-dependent manner. For example, serine MCBAs enhanced C. difficiles ability to grow in otherwise inhibitory bile acid concentrations, increased spore production, and elevated toxin activity. Tryptophan MCBAs increased inhibition. By demonstrating these variable effects, our work clarifies the molecular determinants of MCBA activity and highlights specific MCBAs as promising targets for the development of C. difficile microbial-based therapeutics.

microbiology↗

Magnetic organelle gene clusters enable bacterial growth and ATP homeostasis under oxidizing conditions

Biological organisms can produce magnetic nanoparticles made of magnetite to detect the Earth's magnetic field for orientation. The evolutionary mechanisms that led to the acquisition of this capacity remain unknown. The most ancient organisms known to perform magnetic orientation are magnetotactic bacteria. Under tight genetic control, they produce chains of magnetite nanoparticles in dedicated organelles to allow efficient navigation in aquatic environments containing molecular oxygen. Yet, these bacteria have been proposed to emerge before molecular oxygen became abundant on Earth, at a time when this navigation system could not have served its current function. Here, we show that gene clusters responsible of magnetite formation and organization enable resistance against hydrogen peroxide, a toxic oxygen-derived compound that was produced during the early stages of Earth's oxygenation when iron oxidation consumed molecular oxygen. Characterization of the nanoparticle's oxidation state supported the involvement of magnetite in resistance to hydrogen peroxide-induced oxidative stress. These findings are compatible with an early emergence of magnetotactic bacteria, before natural waters became oxygenated. We propose a conceptual framework to explain the origin of magnetic orientation in bacteria, and offer tools to identify the initiation of Earth's oxygenation in a time-resolved manner.

microbiology↗

Identification and characterization of new P. aeruginosa phages using a surface receptor platform

Bacteriophages are of increasing interest for their potential use as alternatives to antibiotics for treating drug-resistant infections. Phage steering, specifically receptor-based steering, involves use of phages that bias the development of resistance in bacteria towards phenotypes such as reduced fitness. Phage therapy typically involves administering cocktails of phages with different targets to reduce the likelihood of resistance emerging. To ensure effective steering and cocktail design, there is a need to identify the receptors used by phages of interest, and to isolate phages that use diverse receptors. Here we describe a SURFAce Receptor (SURFAR) platform consisting of a set of defined Pseudomonas aeruginosa strains and mutants for rapid characterization of phage receptors. This platform can also be used to enrich for and isolate diverse phages from environmental samples, yielding novel phage genomes from wastewater. Using the SURFAR platform, two new phages were isolated and characterized: Dalewood, which targets both flagella and the conserved LPS outer core, and Bowman, a biofilm targeting phage capable of supressing growth of a subset of carbapenem-resistant clinical isolates. This tool helps to standardize the laborious but important task of phage receptor characterization, with the goal of expanding the known repertoire of P. aeruginosa phage receptors and phages.

microbiology↗